Evaluation of Renal Impairment Influence on Metabolic Drug Clearance using a Modelling Approach-Reference-Cited by-同舟云学术

Evaluation of Renal Impairment Influence on Metabolic Drug Clearance using a Modelling Approach

Published:2023-01-11 Issue:2 Volume:62 Page:307-319
ISSN:0312-5963
Container-title:Clinical Pharmacokinetics
language:en
Short-container-title:Clin Pharmacokinet

Author:

Tuloup Vianney,Goutelle Sylvain,Tod Michel,Bourguignon Laurent^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s40262-022-01205-3.pdf

Reference75 articles.

1. Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M, et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2020;395:709–33.

2. Meier P, Saudan P, Burnier M, Martin PY. Comorbidité et facteurs de risque cardiovasculaire liés à l’insuffisance rénale chronique. Médecine Hygiène. 2003;61:441–50.

3. Santos-Díaz G, Pérez-Pico AM, Suárez-Santisteban MÁ, García-Bernalt V, Mayordomo R, Dorado P. Prevalence of potential drug-drug interaction risk among chronic kidney disease patients in a Spanish hospital. Pharmaceutics. 2020;12:713.

4. Marquito AB, da Fernandes NMS, Colugnati FAB, de Paula RB, Marquito AB, da Fernandes NMS, et al. Interacoes medicamentosas potenciais em pacientes com doenca renal cronica. Braz J Nephrol. 2014;36:26–34.

5. Rama M, Viswanathan G, Acharya LD, Attur RP, Reddy PN, Raghavan SV. Assessment of drug-drug interactions among renal failure patients of nephrology ward in a south Indian tertiary care hospital. Indian J Pharm Sci. 2012;74:63.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Zibotentan Can Be Co‐administered with Contraceptives Containing Ethinyl Estradiol and Levonorgestrel: A Pharmacokinetic Drug–Drug Interaction Study;Clinical Pharmacology & Therapeutics;2024-04-30

2. Developing precision‐based multidisciplinary pharmacotherapy management plans in the critically ill;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2023-09-29